RUDOLPH v. ABBOTT LABORATORIES, INC.

CourtDistrict Court, D. New Jersey
DecidedMarch 2, 2021
Docket3:18-cv-06071
StatusUnknown

This text of RUDOLPH v. ABBOTT LABORATORIES, INC. (RUDOLPH v. ABBOTT LABORATORIES, INC.) is published on Counsel Stack Legal Research, covering District Court, D. New Jersey primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
RUDOLPH v. ABBOTT LABORATORIES, INC., (D.N.J. 2021).

Opinion

UNITED STATES DISTRICT COURT FOR THE DISTRICT OF NEW JERSEY

RICHARD RUDLOPH, Civil Action No.: 3:18-cv-06071 Plaintiff,

MEMORANDUM AND ORDER v.

ABBOTT LABORATORIES, INC.,

Defendant.

Plaintiff Richard Rudolph (“Rudolph” or “Plaintiff”) brings this employment discrimination suit under the Age Discrimination in Employment Act, 29 U.S.C. § 621, et seq. (“ADEA”) and the New Jersey Law Against Discrimination, N.J. Stat. Ann. § 10:5-1, et seq. (“NJLAD”). He argues that his employer, Defendant Abbott Laboratories, Inc. (“Abbott” or “Defendant”) discriminated against him based on his age when it terminated him in 2017. Presently before the Court is Defendant’s motion for summary judgment. (ECF No. 48). For the reasons that follow, Defendant’s motion is denied.

FACTUAL BACKGROUND

A. DEFENDANT’S ORGANIZATIONAL STRUCTURE AND PERFORMANCE STANDARDS Abbott is a global healthcare company with various operations, including pharmaceuticals, medical devices, nutrition, and diagnostic testing. (Def.’s Statement Undisputed Material Facts (“DSUMF”) ¶ 1, ECF No. 48-2). The company is composed of several different business units, one of which is Abbott Diagnostics. (Id.). Within Abbott Diagnostics is Abbott Point of Care (“APOC”) – an organization that develops medical diagnostic testing. (Id. at ¶ 1-2). As relevant to this case, APOC’s two primary product lines are the i-STAT and Piccolo. (Id. at ¶ 2-3). Both are handheld devices that allow a health care provider to perform diagnostic tests. (Id.). APOC is divided into three sales teams that focus on different end-user customers: International, Large Hospital, and Channel. (Id. at ¶ 5). Channel’s sales target distributor and

ambulatory end-user customers, such as medical offices, urgent care centers, and small hospitals. (Id. at ¶ 6). Large Hospitals only sells the i-STAT product directly to large hospitals. (Id. at ¶ 7). The Channel and Large Hospital teams report to the Divisional Vice President for U.S. Commercial Sales, while the International team is under separate leadership. (Id. at ¶ 8). Plaintiff was employed by Abbott for approximately fifteen years. He served in various sales positions between 1995 and 2003, at which point he left the company to pursue other opportunities. (Pl.’s Counterstatement of Facts Opp. Def.’s Mot. Summ. J. (“PCSF”) ¶¶ 7-14, ECF No. 54-3; DSUMF ¶ 12). In 2009, he returned to Abbott as a Marketing Manager for the Channel team. (Id.). He was promoted to Sales Director of that team in May 2010. (DSUMF ¶ 12; PCSF ¶ 19). In that role, Plaintiff directly oversaw three Regional Sales Managers who, in

turn, supervised twenty-one sales representatives. (Id. ¶ 13; Pl.’s Response to Def.’s Statement Material Facts (“PRDSUMF”) ¶ 13, ECF No. 54-2). In or around May 2015, Jeffrey Devlin became the Divisional Vice President for U.S. Commercial Sales of APOC. (DSUMF ¶ 9). Plaintiff reported directly to Devlin. (Id. at ¶ 10). Also reporting directly to Devlin was Mark Klopping, the General Manager for the Large Hospitals team. (Id. at ¶ 11). Devlin is approximately six years younger than Plaintiff, and Klopping and Plaintiff are approximately the same age.1 (DSUMF ¶ 11; PCSF ¶ 1).

1 Plaintiff was born in 1961, Klopping in 1960, and Devlin in 1967. (PCSF ¶ 1; Def.’s Mot. Summ. J. Ex. 8, ECF No. 48-9; PCSF ¶ 50). Abbott, and APOC specifically, had monthly and annual internal sales quotas, known as “plans,” for each product. (DSUMF ¶ 4, 14). Plans are internal goals that are not reported outside Abbott, unlike the company’s sales numbers. (Dep. of Jeffrey Devlin (“Devlin Dep.”) 72:1 – 73:22, Ex. 13, ECF No. 54-5). Corporate leaders within Abbot Diagnostics set plans each

year, which are divided into smaller subsets and assigned to individual sales directors, regional sales managers, and sales representatives. (Id. ¶ 15). Supervisors have discretion to allocate plans among the employees who directly report to them. (Id. ¶ 15). As such, Devlin received the national plan from his supervisor and then determined how to distribute it between Plaintiff and Klopping who, in turn, allocated plans among their direct reports. (Id.; see also Devlin Dep. 77:7 – 78:7, ECF No. 54-5). Meeting plan was an elevated priority under Devlin’s leadership, and was tied to employees’ assessments, incentives, and continued employment. (DSUMF ¶ 19- 22). The sales targets within the Plan and whether Plaintiff achieved the targets are subject to dispute between Plaintiff and Devlin. Plaintiff points to several markers of his strong

performance as Channel Sales Director. (See Pl.’s Opp. Br. 8-11, ECF No. 54). For example, he testified that, before Devlin became his supervisor, he increased Channel’s annual business from under $30 million to over $90 million, with positive growth each year. (PCSF ¶ 20). In addition, he exceeded plan four times, earned the President’s Award2 four times, and received an overall rating of “exceeded expectations” twice and “achieved expectations” three times. (Id. ¶ 21, 30-37, 48). He also cites consistently positive reviews from his former supervisors; even

2 President’s Club is an award that reflects an employee’s sales relative to others. It is based on an employee’s fulfilment of his or her plan rather than revenue in sales. The top-ranked employees are eligible to go on a winner’s trip. (Devlin Dep. 207:8 – 210:6, ECF No. 48-5). when he missed plan by 5% in 2011, and by 1.7% in 2014, he still received a rating of “achieved expectations.”3 (See id. ¶ 24-30, 42-43). In 2015, Plaintiff’s first year reporting to Devlin, he exceeded plan, was rated “achieved expectations,” and received the President’s Club Award, even though he did not meet plan for

each product during each month of that year. (PCSF ¶ 60-62; DSUMF ¶ 23). During his 2015 performance review, Devlin gave Plaintiff positive feedback but also noted several areas for improvement, such as managing underperformers on his team. (PCSF ¶ 64; DSUMF ¶ 24-26, PRSMF ¶ 25-26; Plaintiff’s 2015 Performance Review, ECF No. 48-7). At the end of 2015, Defendant terminated Gary Hamil – one of the three Regional Managers Plaintiff supervised – because, as Plaintiff acknowledged, he had repeated performance and core competency issues over the course of two years and missed plan by nearly 30%. (DSUMF ¶ 28; PRDSUMF ¶ 28). Hamil was approximately the same age as Plaintiff and was replaced with Francisco Merrill, who was significantly younger, upon Plaintiff’s recommendation.4 (DSUMF ¶ 28, 32; PRDSUMF ¶ 28, 32). Merrill joined Ron Gonzales and

Andy Bielitz – the two other Regional Managers who reported to Plaintiff – on the Channel team. (DSUMF ¶ 33). Bielitz and Gonzales are close in age to Plaintiff.5 B. PLAINTIFF’S 2016 PERFORMANCE In 2016, the Channel team fell behind on its monthly plans and appeared to be on track to miss the annual plan. (Id. ¶ 34). As a result, Devlin and Plaintiff had several strategy calls

3 Plaintiff attributes his failure to meet plan in 2014 to the fact that the 2014 sales plan increased by nearly 20 million dollars from the previous year. (PRDSUMF ¶ 18). He maintains that he increased Channel’s sales by nearly 11.5 million dollars that year, and that his supervisor at the time wrote that “2014 was yet another successful year for Rich and the Channel organization,” and that he was “a valuable member of my direct staff.” (Id.).

4 Merrill was born in 1977 and Hamil in 1961. (Def.’s Mot. Summ. J. Ex. 8, ECF No. 48-9).

5 Bielitz was born in 1960 and Gonzales in 1964. (Def.’s Mot. Summ. J. Ex. 8, ECF No. 48-9). during which Devlin stressed the importance of capital sales and directed Plaintiff to improve his sales forecasting accuracy. (Id. ¶ 35-38; PRDSUMF ¶ 35-38).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

McDonnell Douglas Corp. v. Green
411 U.S. 792 (Supreme Court, 1973)
Trans World Airlines, Inc. v. Thurston
469 U.S. 111 (Supreme Court, 1985)
Anderson v. Liberty Lobby, Inc.
477 U.S. 242 (Supreme Court, 1986)
Reynolds v. Department of Army
439 F. App'x 150 (Third Circuit, 2011)
Ricardo Jalil v. Avdel Corporation
873 F.2d 701 (Third Circuit, 1989)
Caroline Dellapenna v. Tredyffrin/easttown School Dis
449 F. App'x 209 (Third Circuit, 2011)
Richard J. Kautz v. Met-Pro Corporation
412 F.3d 463 (Third Circuit, 2005)
Lawrence Robinson v. City of Philadelphia
491 F. App'x 295 (Third Circuit, 2012)
Angela Ekhato v. Rite Aid Corp
529 F. App'x 152 (Third Circuit, 2013)
Hunt v. Cromartie
526 U.S. 541 (Supreme Court, 1999)
Ziegler v. Delaware County Daily Times
128 F. Supp. 2d 790 (E.D. Pennsylvania, 2001)
Dungee v. Northeast Foods, Inc.
940 F. Supp. 682 (D. New Jersey, 1996)

Cite This Page — Counsel Stack

Bluebook (online)
RUDOLPH v. ABBOTT LABORATORIES, INC., Counsel Stack Legal Research, https://law.counselstack.com/opinion/rudolph-v-abbott-laboratories-inc-njd-2021.